On December 2, 2017, the Tax Cuts and Jobs Act was passed in the US Senate, and the House version was passed in November 2017. The US medtech industry is expected to be impacted by some key reforms in the bill such as corporate tax cuts, repeal of the tax deduction for people with high medical expenses, and a 20% excise tax imposed on goods manufactured outside the United States by US companies’ subsidiaries.

Major medtech players such as Medtronic (MDT), Becton Dickinson (BDX), Zimmer Biomet Holdings (ZBH), and Intuitive Surgical (ISRG) are closely following the developments around the tax reform bills. This legislation is expected to have a significant impact on their sales and growth going forward.

How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry

Investors can consider the iShares U.S. Medical Devices ETF (IHI) for focused exposure to the US medtech industry. Medtronic, Becton Dickinson, Zimmer Biomet Holdings, and Zimmer Biomet Holdings comprise approximately 10.2%, 5.8%, 3.2%, and 5.3%, respectively, of IHI’s total portfolio holdings.

Corporate tax cuts and R&D

The permanent corporate tax rate cut from 35% to 20% is the major tax reform proposed in both tax reform bills. The tax cuts are expected to significantly boost the research and development (or R&D) expenses and innovation in the medtech industry.

However, the repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.

This complex interaction of legislation, tax law, and medtech could also provide benefits to some players in the US medical device industry that offer generic therapies and procedures.

Latest articles

Today, Canopy Growth announced that it acquired the Saskatchewan-based KeyLeaf Life Sciences along with entities relating to the company and its intellectual property. Here's what you need to know about the completed deal.

Yesterday, Tyson Foods (TSN) and fellow meat producers Pilgrim’s Pride (PPC) and Sanderson Farms (SAFM) took a hit to their stocks after news came out about an investigation over price-fixing allegations.

On June 24, RH (RH) was trading at $115.01, implying a rise of 21.2% since its announcement of its first-quarter earnings results on June 12. Despite the surge in its stock price, the company is still trading at a discount of 29.1% to its 52-week high.

26 Jun

Roku Stock Fell Close to 7.0% Yesterday

WRITTEN BY Aditya Raghunath

Roku stock fell 6.8% yesterday to close trading at $93.25 per share. Roku stock has lost over 9.0% in market value in the last two trading days. Prior to this pullback, Roku stock was up a whopping 235.0% year-to-date.

26 Jun

Beyond Meat Stock Up Today on New Product Launch

WRITTEN BY Rajiv Nanjapla

Today, Beyond Meat (BYND) announced that its new product, Beyond Beef, will hit markets across the US later this week.

FedEx (FDX) ended fiscal 2019 on a dismal note and reported a significant YoY decline in fourth-quarter earnings. The delivery giant posted adjusted EPS of $5.01, which was 15.2% lower than the year-ago quarter’s earnings of $5.91. The company cited sluggish revenue growth and increased expenses as the main reason behind the dismal bottom-line performance.